Elias Schlie (Longevity)
Elias Schlie (Longevity)
Elias Schlie
#43 The 3 Bottlenecks in Longevity Medicine - Alexey Strygin - Longevity pop up villages; Longevity Economics Think Tanks; Zelar City; Zuzalu; How to start working in Longevity-Biotech
49 minutes Posted Sep 9, 2024 at 12:34 pm.
Introduction and Background
Alexey's future in longevity
Why we need Longevity Economics advocacy group
Why longevity pop-up cities are amazing
Why Alexey is excited for Zell City
How Alexey got into longevity
How to get into the longevity field
The best places to learn about longevity
Who do you look up to in the longevity field?
Identifying the Bottlenecks in the Longevity Field
First Bottleneck
Second Bottleneck
Third Bottleneck
How to solve the money bottleneck
Where can a tiny group of dedicated people make impact towards solving aging?
What everybody can do right now
Outro
0:00
49:20
Download MP3
Show notes
Alexey Strygin is working in the longevity industry for the last 10 years. He was part of the early days of Insilico Medicine and also worked as a Chief Digital Health Officer at Gero.ai.
Links
- ⁠Zelar City Website⁠
- ⁠What is Zelar City?
Summary
Alexey Strygin discusses the importance of Longevity Economics and the need for increased funding in the longevity industry. He suggests the creation of a Longevity Economics Think Tank or Advocacy Group to attract both governmental and private funding. He emphasizes the need for data collection on a large scale and proposes the establishment of a centralized or quasi-centralized effort, similar to the UK Biobank, to accelerate research. Alexey also highlights the importance of convincing resource allocators, such as billionaires and world leaders, to invest in aging research. He encourages individuals to switch careers, donate, and spread awareness about the industry.
Takeaways
Longevity Economics is an important field that can attract funding and increase the overall amount of funding in the longevity industry.
Data collection on a large scale is crucial for advancing research on aging, and a centralized or quasi-centralized effort is needed to achieve this.
Convincing resource allocators, such as billionaires and world leaders, to invest in aging research is essential for accelerating progress.
Individuals can contribute to the field by switching careers, donating, and spreading awareness about the importance of extending healthy lifespan.
Chapters